A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
entrez:
4
9
2020
pubmed:
4
9
2020
medline:
28
10
2020
Statut:
epublish
Résumé
In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new venture is known as the Research Investment for Global Health Technology (RIGHT) Fund.
Identifiants
pubmed: 32881862
doi: 10.1371/journal.pntd.0007956
pii: PNTD-D-19-01622
pmc: PMC7470318
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0007956Déclaration de conflit d'intérêts
I have read the journal's policy and the authors of this manuscript have the following competing interests: GR has an interest in the financial success of two public health impact investment funds, Global Health Investment Fund I, LLC, and Adjuvant Global Health Technology Fund, LP, where he holds investment advisory roles. Both organizations may benefit from grant funding provided by the organizations described in this publication. Equally, both organizations may be disadvantaged by grant funding provided flowing to competing technologies.
Références
Korean J Parasitol. 2006 Sep;44(3):177-85
pubmed: 16969055
Lancet Glob Health. 2013 Oct;1(4):e184-5
pubmed: 25104343
PLoS Biol. 2017 Nov 9;15(11):e2004186
pubmed: 29121043